Husain Yar Khan

10PUBLICATIONS
41CO-AUTHORS
Molecular targetsCancer cell biologyHaematological tumoursPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jan 23, 2026
Genomic and Transcriptomic Landscapes of MEN1-Wild-Type Low-Grade Metastatic Pancreatic NETs Uncover Key Oncogenic Drivers and Targetable Pathways.

Md Hafiz Uddin, Zaid Mahdi, Irfana Muqbil

|Dec 15, 2025
Co-targeting KRAS and Exportin1 as an effective therapeutic strategy for KRASG12D mutant pancreatic ductal adenocarcinoma.

Husain Yar Khan, Mohammed Najeeb Al Hallak, Amro Aboukameel

|May 07, 2025
Molecular Characterization and Clinical Outcomes of Pancreatic Neuroendocrine Neoplasms Harboring PAK4-NAMPT Alterations.

Ibrahim Azar, Husain Yar Khan, Sahar F Bannoura

|Jan 08, 2024
Regulator of Chromosome Condensation (RCC1) a novel therapeutic target in pancreatic ductal adenocarcinoma drives tumor progression via the c-Myc-RCC1-Ran axis.

Sahar F Bannoura, Amro Aboukameel, Husain Yar Khan

|Sep 13, 2023
Anticancer Efficacy of KRASG12C Inhibitors Is Potentiated by PAK4 Inhibitor KPT9274 in Preclinical Models of KRASG12C-Mutant Pancreatic and Lung Cancers.

Husain Yar Khan, Misako Nagasaka, Amro Aboukameel

|Apr 10, 2023
Anticancer efficacy of KRASG12C inhibitors is potentiated by PAK4 inhibitor KPT9274 in preclinical models of KRASG12C mutant pancreatic and lung cancers.

Husain Yar Khan, Misako Nagasaka, Amro Aboukameel

Pageof 2

Frequent Collaborators

7 joint publications

Asfar S Azmi

6 joint publications

Md Hafiz Uddin

3 joint publications

Mohammed Najeeb Al-Hallak

3 joint publications

Misako Nagasaka